Mark Kelly
University of Massachusetts Chan Medical School(US)UMass Memorial Medical Center(US)
Publications by Year
Research Areas
Liver Disease Diagnosis and Treatment, Adipose Tissue and Metabolism, Adipokines, Inflammation, and Metabolic Diseases, Liver physiology and pathology, Lipid metabolism and biosynthesis
Most-Cited Works
- → IRF3 and type I interferons fuel a fatal response to myocardial infarction(2017)554 cited
- → Collagen‐platelet rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament(2006)318 cited
- → Single-Cell RNA Profiling Reveals Adipocyte to Macrophage Signaling Sufficient to Enhance Thermogenesis(2020)86 cited
- → CRISPR-enhanced human adipocyte browning as cell therapy for metabolic disease(2021)83 cited
- → Control of Adipocyte Thermogenesis and Lipogenesis through β3-Adrenergic and Thyroid Hormone Signal Integration(2020)65 cited
- → CRISPR-delivery particles targeting nuclear receptor–interacting protein 1 (Nrip1) in adipose cells to enhance energy expenditure(2018)58 cited
- → De novo lipogenesis fuels adipocyte autophagosome and lysosome membrane dynamics(2023)50 cited
- → An RNAi therapeutic targeting hepatic DGAT2 in a genetically obese mouse model of nonalcoholic steatohepatitis(2021)45 cited
- → Neuronal modulation of brown adipose activity through perturbation of white adipocyte lipogenesis(2018)39 cited
- → Neural JNK3 regulates blood flow recovery after hindlimb ischemia in mice via an Egr1/Creb1 axis(2019)31 cited